These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32282391)

  • 21. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
    Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
    Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure.
    Uechi M; Asai K; Sato N; Vatner SF
    Circulation; 1998 Sep; 98(13):1342-7. PubMed ID: 9751685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baroreceptor stimulation in a patient with preexisting subcutaneous implantable cardioverter defibrillator.
    Weipert KF; Andrick J; Chasan R; Gemein C; Most A; Hamm CW; Erkapic D; Schmitt J
    Pacing Clin Electrophysiol; 2018 Jan; 41(1):90-92. PubMed ID: 28543399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Failure: Heart Failure With Reduced Ejection Fraction.
    Barnhouse K
    FP Essent; 2021 Jul; 506():20-26. PubMed ID: 34264589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to the treatment of advanced heart failure: a case report.
    Robles-Mezcua A; Villaescusa-Catalán JM; Melero-Tejedor JM; García-Pinilla JM
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa541. PubMed ID: 33738406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
    Wallbach M; Koziolek MJ; Wachter R
    Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care.
    Mastoris I; Spall HGCV; Sheldon SH; Pimentel RC; Steinkamp L; Shah Z; Al-Khatib SM; Singh JP; Sauer AJ
    J Card Fail; 2022 Jun; 28(6):991-1015. PubMed ID: 34774748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
    McDonald M; Virani S; Chan M; Ducharme A; Ezekowitz JA; Giannetti N; Heckman GA; Howlett JG; Koshman SL; Lepage S; Mielniczuk L; Moe GW; O'Meara E; Swiggum E; Toma M; Zieroth S; Anderson K; Bray SA; Clarke B; Cohen-Solal A; D'Astous M; Davis M; De S; Grant ADM; Grzeslo A; Heshka J; Keen S; Kouz S; Lee D; Masoudi FA; McKelvie R; Parent MC; Poon S; Rajda M; Sharma A; Siatecki K; Storm K; Sussex B; Van Spall H; Yip AMC
    Can J Cardiol; 2021 Apr; 37(4):531-546. PubMed ID: 33827756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-pharmacological modulation of the autonomic tone to treat heart failure.
    Singh JP; Kandala J; Camm AJ
    Eur Heart J; 2014 Jan; 35(2):77-85. PubMed ID: 24174128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
    Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.
    Ziaeian B; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2014 Aug; 64(8):797-807. PubMed ID: 25145524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.
    Seravalle G; Grassi G
    High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):233-9. PubMed ID: 25813853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial baroreflex regulation of blood pressure in patients with congestive heart failure.
    Creager MA; Creager SJ
    J Am Coll Cardiol; 1994 Feb; 23(2):401-5. PubMed ID: 8294694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Interventional Therapies to Modulate the Autonomic Tone in Heart Failure.
    Chatterjee NA; Singh JP
    JACC Heart Fail; 2015 Oct; 3(10):786-802. PubMed ID: 26364257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baroreceptor Stimulation for Resistant Hypertension.
    Yoruk A; Bisognano JD; Gassler JP
    Am J Hypertens; 2016 Dec; 29(12):1319-1324. PubMed ID: 27444637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.